BEIJING - Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company.
|
 Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company. [Photo?by Xie Changgui / Asianewsphoto] |
The circular, jointly issued by the China Food and Drug Administration (CFDA) and the National Health and Family Planning Commission (NHFPC), said that four cases of infants' deaths were reported in Hunan, Guangdong and Sichuan provinces after inoculation using the vaccine.
The CFDA and the NHFPC will carry out further investigation into the cases and inspection over the company , the circular said.
|
 Doctors check on an infant affected by the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company, Dec 13, 2013. [Photo by Xie Changgui / Asianewsphoto]??Drug companies see sales rise 18% in 2012 |
|
|
|
|
|
|
|
|
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
Op Rana
Berlin Fang
Zhu Yuan
Huang Xiangyang
Chen Weihua
Liu Shinan